戻る
Biopharmaceutical Sector Navigates Strategic Shifts and Clinical Advancements
戻る
株式ニュース
テーマ
Biopharmaceutical Sector Navigates Strategic Shifts and Clinical Advancements
CAR-T療法
Biopharmaceutical Sector Navigates Strategic Shifts and Clinical Advancements
Edgen Stock
·
Sep 20 2025, 14:49
共有先
共有先
リンクをコピー
ソース：
[1] Arvinas reboots, cuts more staff; Porges joins Lazard | BioPharma Dive
[2] Arvinas Provides Update on Collaboration with Pfizer and Announces Further Actions to Support Value Creation - BioSpace
[3] Arvinas To Cut Jobs, Out-License Vepdegestrant, And Launch $100 Mln Stock Buyback Plan | Nasdaq
Edgen Stock·Sep 20 2025, 14:49Edgen Stock·Sep 20 2025, 14:49
Edgen Stock·Sep 20 2025, 14:49